Does Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect?

Intellia Therapeutics, Inc. (NTLA) closed the last trading session at $9.64, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $50.36 indicates a 422.4% upside potential.The average comprises 22 short-term price targets ranging from a low of $10 to a high of $106, with a standard deviation of $29.45. While the lowest estimate indicates an increase of 3.7% from the curren ...